The literature has shown that chemotherapy directly results in an upregulation of various well-known pro-inflammatory mediators, such as IL-1β, TNF-α, MCP-1, IL-6, etc., which contribute to symptoms including but not limited to fatigue, peripheral neuropathy, and cognitive decline [25]. This evidence concerns the gene IL6 and peripheral neuropathy.